Skip to main content
Equibles
KRMD logo

KRMD · KORU Medical Systems, Inc. · Earnings Call Transcripts & Audio

Track KRMD — free

Use KRMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KRMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.16 +0.01 (+0.32%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$145.90M
Shares
46.17M

KORU Medical Systems, Inc. Earnings Call Transcripts

Quarterly earnings calls for KORU Medical Systems, Inc. (KRMD), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲28.5% $7.76M −$1.23M '22 Q3 22-11-09 ▲13.2% $7.34M −$1.98M '22 Q4 23-03-08 ▲18.4% $7.39M −$2.41M '23 Q1 23-05-04 ▲5.9% $6.94M −$2.50M '23 Q2 23-08-09 ▼9.8% $7.00M −$1.37M '23 Q3 23-11-08 ▼2.2% $7.19M −$7.47M '23 Q4 24-03-13 ▲10.9% $8.20M −$1.94M '24 Q1 24-05-01 ▲21.5% $8.43M −$988,715 '24 Q2 24-08-07 ▲16.8% $8.18M −$1.58M '24 Q3 24-11-13 ▲23% $8.84M −$1.56M '24 Q4 25-03-12 ▲17.5% $9.64M −$1.17M '25 Q1 25-05-07 ▲20.9% $10.19M −$206,867 '25 Q2 25-08-06 ▲27.2% $10.40M −$777,966 '25 Q3 25-11-12 ▲23.3% $10.90M −$486,856 '25 Q4 26-03-12 ▲22.1% $11.76M −$807,078 '26 Q1 26-05-06 LATEST ▲18.2% $12.05M $252,449 '26 Q2 26-08-05
Conference
Investor event
2026-08-12
KORU Medical Systems, Inc. (KRMD) August 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-05
KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript
Confident tone International expansion (pre-filled syringe markets) Secondary immunodeficiency (SID) opportunity Domestic core IG growth and market share
Revenue
$12.05M
▲ 18.2% YoY
Diluted EPS
$0.01
Gross margin
65.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
KORU Medical Systems, Inc. (KRMD) Q1 2026 Earnings Call Transcript
Confident tone SID (secondary immunodeficiency) opportunity Non-IG pipeline and drug expansion Domestic core business growth
Revenue
$11.76M
▲ 22.1% YoY
Diluted EPS
$-0.02
Gross margin
61.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-12
KORU Medical Systems, Inc. (KRMD) Q4 2025 Earnings Call Transcript
Confident tone Revenue growth and full year results RYSTIGGO and infusion clinic channel 2026 guidance and outlook
Revenue
$10.90M*
▲ 23.3% YoY
Gross margin
62.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
KORU Medical Systems, Inc. (KRMD) Q3 2025 Earnings Call Transcript
Confident tone US SCIG Core Business International Expansion and Prefilled Syringes Oncology Infusion Opportunity
Revenue
$10.40M
▲ 27.2% YoY
Diluted EPS
$0.02
▼ 33.3% YoY
Gross margin
60.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript
Confident tone Guidance and Forward Outlook Core Domestic Business New Drug Pipeline and Label Expansions
Revenue
$10.19M
▲ 20.9% YoY
Diluted EPS
$0.00
▼ 100% YoY
Gross margin
63.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
KORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call Transcript
Confident tone International expansion Tariffs and gross margin 510(k) submissions and new drugs on label pipeline
Revenue
$9.64M
▲ 17.5% YoY
Diluted EPS
$-0.03
▼ 175% YoY
Gross margin
62.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-12
KORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call Transcript
Confident tone International Expansion Domestic Core Business and SCIg Market Tariffs and Supply Chain
Revenue
$8.84M*
▲ 23% YoY
Gross margin
62.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-13
KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript
Confident tone Novel Therapies Pipeline Domestic Core SCIg Business International Expansion
Revenue
$8.18M
▲ 16.8% YoY
Diluted EPS
$0.03
Gross margin
63.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
KORU Medical Systems, Inc. (KRMD) Q2 2024 Earnings Call Transcript
Confident tone International Expansion Novel Therapies / Pipeline Collaborations Core Domestic SCIg Business Growth
Revenue
$8.43M
▲ 21.5% YoY
Diluted EPS
$0.02
Gross margin
65.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
KORU Medical Systems, Inc. (KRMD) Q1 2024 Earnings Call Transcript
Confident tone Novel Therapies pipeline and collaborations International expansion and BSI/MDR regulatory progress 2024 guidance reaffirmation
Revenue
$8.20M
▲ 10.9% YoY
Diluted EPS
$0.04
Gross margin
62.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-13
KORU Medical Systems, Inc. (KRMD) Q4 2023 Earnings Call Transcript
Positive tone Novel Therapies Pipeline International Expansion Domestic SCIg Core Business
Revenue
$7.19M*
▼ 2.2% YoY
Gross margin
60.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-08
KORU Medical Systems, Inc. (KRMD) Q3 2023 Earnings Call Transcript
Revenue
$7.00M
▼ 9.8% YoY
Diluted EPS
$-0.03
Gross margin
62.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
KORU Medical Systems, Inc. (KRMD) Q2 2023 Earnings Call Transcript
Revenue
$6.94M
▲ 5.9% YoY
Diluted EPS
$-0.05
Gross margin
56.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
KORU Medical Systems, Inc. (KRMD) Q1 2023 Earnings Call Transcript
Revenue
$7.39M
▲ 18.4% YoY
Diluted EPS
$-0.05
Gross margin
56.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-08
KORU Medical Systems, Inc. (KRMD) Q4 2022 Earnings Call Transcript
Revenue
$7.34M*
▲ 13.2% YoY
Gross margin
55.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-09
KORU Medical Systems, Inc. (KRMD) Q3 2022 Earnings Call Transcript
Revenue
$7.76M
▲ 28.5% YoY
Diluted EPS
$-0.03
Gross margin
55.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
KORU Medical Systems, Inc. (KRMD) Q2 2022 Earnings Call Transcript
Revenue
$6.55M
▲ 18.4% YoY
Diluted EPS
$-0.07
Gross margin
51.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
KORU Medical Systems, Inc. (KRMD) Q1 2022 Earnings Call Transcript
Revenue
$6.24M
▲ 15% YoY
Diluted EPS
$-0.06
Gross margin
58.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-02
KORU Medical Systems, Inc. (KRMD) Q4 2021 Earnings Call Transcript
Revenue
$6.49M*
▲ 60% YoY
Gross margin
59.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
KORU Medical Systems, Inc. (KRMD) Q3 2021 Earnings Call Transcript
Revenue
$6.04M
▼ 0.7% YoY
Diluted EPS
$-0.02
▼ 300% YoY
Gross margin
57.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-11
KORU Medical Systems, Inc. (KRMD) Q2 2021 Earnings Call Transcript
Revenue
$5.53M
▼ 28.3% YoY
Diluted EPS
$-0.03
Gross margin
58.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-12
KORU Medical Systems, Inc. (KRMD) Q1 2021 Earnings Call Transcript
Revenue
$5.43M
▼ 14.2% YoY
Diluted EPS
$-0.03
▼ 400% YoY
Gross margin
59.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-01-26
KORU Medical Systems, Inc. (KRMD) Q4 2020 Earnings Call Transcript
Revenue
$4.06M*
▼ 34.8% YoY
Gross margin
56.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-04
KORU Medical Systems, Inc. (KRMD) Q3 2020 Earnings Call Transcript
Revenue
$6.08M
▼ 8.1% YoY
Diluted EPS
$0.01
▼ 50% YoY
Gross margin
64.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
KORU Medical Systems, Inc. (KRMD) Q2 2020 Earnings Call Transcript
Revenue
$7.71M
▲ 44.1% YoY
Diluted EPS
$-0.03
Gross margin
63.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
KORU Medical Systems, Inc. (KRMD) Q1 2020 Earnings Call Transcript
Revenue
$6.33M
▲ 27.3% YoY
Diluted EPS
$0.01
Gross margin
59.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
KORU Medical Systems, Inc. (KRMD) Q4 2019 Earnings Call
Revenue
$6.22M*
▲ 45.7% YoY
Gross margin
63.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 earnings calls
Key facts CIK 704440 CUSIP 759910102 13F (30d) 26 filings 26 filers Visit website Investor relations